FLT3 Antikörper (pTyr842)
Kurzübersicht für FLT3 Antikörper (pTyr842) (ABIN7139079)
Target
Alle FLT3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pTyr842
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
-
Immunogen
- Peptide sequence around phosphorylation site of tyrosine 842(S-N-Y(p)-V-V) derived from Human FLT3 .
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:1000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))
-
Andere Bezeichnung
- FLT3
-
Hintergrund
-
Background:
FLT3 encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.
Small D., Proc. Natl. Acad. Sci. U.S.A. 91:459-463(1994).
Rosnet O., Blood 82:1110-1119(1993).
Rosnet O., Genomics 9:380-385(1991).Aliases: CD 135 antibody, CD135 antibody, CD135 antigen antibody, Fetal liver kinase 2 antibody, FL cytokine receptor antibody, Flk 2 antibody, Flk2 antibody, Flt 3 antibody, FLT-3 antibody, Flt3 antibody, FLT3_HUMAN antibody, FMS like tyrosine kinase 3 antibody, Fms related tyrosine kinase 3 antibody, Fms-like tyrosine kinase 3 antibody, Growth factor receptor tyrosine kinase type III antibody, Ly-72 antibody, OTTHUMP0000004234 antibody, Receptor type tyrosine protein kinase FLT3 antibody, Stem cell tyrosine kinase 1 antibody, Stk 1 antibody, STK-1 antibody, Stk1 antibody, Tyrosine protein kinase receptor FLT3 antibody, Tyrosine-protein kinase receptor FLT3 antibody
-
UniProt
- P36888
-
Pathways
- RTK Signalweg
Target
-